Summary BNT162b2 and mRNA‐1273 are two types of mRNA‐based vaccine platforms that
have received emergency use authorization. The emergence of novel severe acute …

Effective and safe vaccines are invaluable tools in the arsenal to fight infectious diseases.
The rapid spreading of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

We summarize here in vitro evidences of efficacy for convalescent plasma, currently
approved vaccines and monoclonal antibodies against SARS-CoV-2 variants of concern …

Boosting protein production is invaluable in both industrial and academic applications. We
discovered a novel expression-increasing 21-mer cis-regulatory motif (Exin21) that inserts …

COVID-19 vaccines are highly protective against severe disease; however, vaccine
breakthrough infections resulting in hospitalization may still occur in a small percentage of …

The WHO emergency use-listed (EUL) COVID-19 vaccines were developed against early
strains of SARS-CoV-2. With the emergence of SARS-CoV-2 variants of concern (VOCs) …

Because the vaccine-elicited antibody and neutralizing activity against spike protein of
SARS-CoV-2 are associated with protection from COVID-19, it is important to determine the …

Real-time reverse transcription polymerase chain reaction (RT-PCR) assays are the most
widely used molecular tests for the detection of SARS-CoV-2 and diagnosis of COVID-19 in …

The level of postvaccine protection depends on two factors: antibodies and T‐cell
responses. While the first one is relatively easily measured, the measuring of the second …

Purpose: COVID-19 vaccines have been shown to be highly effective; however, vaccine
breakthrough infections resulting from hospitalization may still occur in a small percentage of …